MJUS 📈 Amplify Trust - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US26924G7557 • Miscellaneous Sector
MJUS: Cannabis, Stocks, Derivatives
The fund seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the 'Cannabis Business' in the United States, and in derivatives that have economic characteristics similar to such securities. The fund is non-diversified.
Additional Sources for MJUS ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MJUS ETF Overview
| Market Cap in USD | 151m |
| Category | Miscellaneous Sector |
| TER | 0.75% |
| IPO / Inception | 2021-05-12 |
MJUS ETF Ratings
| Growth 5y | -89.3% |
| Fundamental | - |
| Dividend | 21.8% |
| Rel. Strength Industry | -345 |
| Analysts | - |
| Fair Price Momentum | 0.51 USD |
| Fair Price DCF | - |
MJUS Dividends
| Dividend Yield 12m | 9.61% |
| Yield on Cost 5y | 0.79% |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 100.0% |
MJUS Growth Ratios
| Growth Correlation 3m | -94.1% |
| Growth Correlation 12m | -91.5% |
| Growth Correlation 5y | -84.8% |
| CAGR 5y | -49.37% |
| CAGR/Mean DD 5y | -0.72 |
| Sharpe Ratio 12m | -0.95 |
| Alpha | -86.08 |
| Beta | 1.09 |
| Volatility | 69.94% |
| Current Volume | 79.5k |
| Average Volume 20d | 162.6k |
What is the price of MJUS stocks?
As of January 15, 2025, the stock is trading at USD 0.77 with a total of 79,453 shares traded.
Over the past week, the price has changed by -9.15%, over one month by -4.80%, over three months by -47.07% and over the past year by -58.87%.
As of January 15, 2025, the stock is trading at USD 0.77 with a total of 79,453 shares traded.
Over the past week, the price has changed by -9.15%, over one month by -4.80%, over three months by -47.07% and over the past year by -58.87%.
Is Amplify Trust a good stock to buy?
No, based on ValueRay Analyses, Amplify Trust (NYSE ARCA:MJUS) is currently (January 2025) a stock to sell. It has a ValueRay Growth Rating of -89.27 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MJUS as of January 2025 is 0.51. This means that MJUS is currently overvalued and has a potential downside of -33.77%.
No, based on ValueRay Analyses, Amplify Trust (NYSE ARCA:MJUS) is currently (January 2025) a stock to sell. It has a ValueRay Growth Rating of -89.27 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MJUS as of January 2025 is 0.51. This means that MJUS is currently overvalued and has a potential downside of -33.77%.
Is MJUS a buy, sell or hold?
Amplify Trust has no consensus analysts rating.
Amplify Trust has no consensus analysts rating.
What are the forecast for MJUS stock price target?
According to ValueRays Forecast Model, MJUS Amplify Trust will be worth about 0.6 in January 2026. The stock is currently trading at 0.77. This means that the stock has a potential downside of -25.97%.
According to ValueRays Forecast Model, MJUS Amplify Trust will be worth about 0.6 in January 2026. The stock is currently trading at 0.77. This means that the stock has a potential downside of -25.97%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.6 | -26% |